Poole Hospital Cancer Treatment Trust

PHCTT funded only capital projects that enhanced cancer care, such as state-of-the-art equipment, facility expansions, and diagnostic upgrades. These investments supported surgery, radiotherapy, chemotherapy, and research for both adults and children in Dorset. The Trust's focus was strictly on Poole Hospital's cancer units and affiliated NHS services, prioritising high-impact infrastructure over community or general health initiatives. This meant that funding went towards tangible, lasting improvements in the hospital's cancer services, rather than towards broader health programmes or community-based activities.

No external entities were eligible for funding; grants went solely to hospital-identified needs within Poole and Dorset. The Trust did not support other charities, regardless of their size or income. Unsolicited applications were never accepted, and the Trust eschewed core costs, unrestricted funding, trading, or trustee payments. This approach meant that only the hospital's own cancer units and affiliated NHS services could benefit, with funding directed to priorities identified by clinical teams.

The Trust did not fund community or general health initiatives, nor did it support other charities. It also avoided core costs, unrestricted funding, trading, and trustee payments. This meant that funding was exclusively for capital projects within Poole Hospital's cancer services, with no support for external organisations or non-capital expenses.

PHCTT funded only capital projects, with grants awarded internally without open processes. Unsolicited applications were never accepted, and funding decisions were based on hospital-identified needs. The Trust's approach was evidence-driven, focusing on high-impact equipment investments that delivered enduring clinical outcomes. This style of funding, now managed by UHD Charity, continues to prioritise service needs over external requests.